Search
for
Sort by
Research 211–240 of 1000+
- Olumiant® (Baricitinib)-A Newly Approved Janus Kinase Inhibitor for the Treatment of Alopecia Areata.
- 5PSQ-056 Experience with tofacinitib and baricitinib in rheumatoid arthritis
- Combination oral minoxidil and baricitinib treatment of alopecia areata
- Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation
- The manipulation of the cedrol metabolism pathway by baricitinib and its immune interaction mechanism against chemotherapy-induced alopecia
- 61346 Baseline Psychosocial Impact of Disease in Patients with Severe Alopecia Areata Treated with Baricitinib Recruited from the US Customer Support Program
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
- Drugs targeting epithelial–mesenchymal transition molecules for treatment of lichen planopilaris
- JAK inhibitors in dermatology: The promise of a new drug class
- Alopecia Areata: An Updated Review for 2023
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Novel TMEM173 Mutation and the Role of Disease Modifying Alleles
- New and Emerging Therapies for Alopecia Areata
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- New drugs under investigation for the treatment of alopecias
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Janus kinase inhibitors for alopecia areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Emerging drugs for the treatment of alopecia areata